Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (NCT07892664) titled 'Reducing Arterial Inflammation Using Eplerenone and Statins in HIV' on Oct. 18.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Massachusetts General Hospital

Condition: HIV (Human Immunodeficiency Virus) Cardiovascular Diseases (CVD) Arterial Inflammation Heart Disease

Intervention: Drug: Eplerenone

Recruitment Status: Not recruiting

Phase: Phase 2/Phase 3

Date of First Enrollment: March 1, 2027

Target Sample Size: 124

C...